Biofrontera AG - Stock Price History | BFRA

Historical daily share price chart and data for Biofrontera AG since 2021 adjusted for splits. The latest closing stock price for Biofrontera AG as of September 24, 2021 is 5.51.
  • The all-time high Biofrontera AG stock closing price was 30.50 on August 12, 2020.
  • The Biofrontera AG 52-week high stock price is 9.87, which is 79.1% above the current share price.
  • The Biofrontera AG 52-week low stock price is 4.67, which is 15.2% below the current share price.
  • The average Biofrontera AG stock price for the last 52 weeks is 6.60.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Biofrontera AG Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 8.2707 10.3400 30.5000 5.4100 7.2900 -29.50%
2019 13.4751 11.7100 18.2499 9.0000 10.3400 -11.70%
2018 13.5201 12.1800 17.8700 11.2100 11.7100 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.155B $0.036B
Biofrontera AG is a biopharmaceutical company. It engaged in the development and commercialization of a platform of pharmaceutical products for the treatment of dermatological conditions and diseases. The company's products focus on the treatment in the U.S. and Europe of actinic keratoses, which are skin lesions which can sometimes lead to skin cancer as well as the treatment of certain forms of basal cell carcinoma in the European Union. Biofrontera AG is based in Leverkusen, Germany.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71